Peter G. Shields
0000-0002-7404-217X
Publication & Citation Trends
Publications
0 total
Early Acute Kidney Injury and Its Association With Survival in Patients With Metastatic Non‐Small‐Cell Lung Cancer Treated With Front‐Line Immunotherapy‐Based Therapies
Cited by 0
Semantic Scholar
Early Changes in Lymphocyte/Monocyte Ratio on Treatment as a Prognostic Marker to Predict Overall Survival in Patients with Advanced Cancer Treated with Immune Checkpoint Inhibitors
Cited by 0
Semantic Scholar
Abstract 3405: CT-assessed body composition and tumor immunologic characteristics in patients with non-small-cell lung cancer
Cited by 0
Semantic Scholar
mRNA vaccines against SARS-CoV-2 induce divergent antigen-specific T-cell responses in patients with lung cancer OA
Cited by 6
Semantic Scholar
Eosinophil-neutrophil ratio as a sex-dependent prognostic marker in immune checkpoint therapy for metastatic NSCLC and transcriptomic evaluation of intratumoral eosinophil-T cell interaction.
Cited by 1
Semantic Scholar
Abstract 3404: Body weight trajectory among patients with non-small-cell lung cancer receiving immune checkpoint inhibitors
Cited by 0
Semantic Scholar
Functional resilience and overall survival in adults treated for advanced non-small-cell lung cancer.
Cited by 5
Semantic Scholar
Selective suppression of de novo SARS-CoV-2 vaccine antibody responses in patients with cancer on B cell–targeted therapy OA
Cited by 2
Semantic Scholar
Research Topics
Smoking Behavior and Cessation
(85)
Carcinogens and Genotoxicity Assessment
(61)
Epigenetics and DNA Methylation
(55)
Cancer Risks and Factors
(45)
Glutathione Transferases and Polymorphisms
(42)
Affiliations
University of North Carolina at Chapel Hill
University of Bern
Tufts University
City College of New York
University of Maryland, Baltimore